Axin degradation was significant in both peak allergy and off-peak season allergy sufferers compared to HCs, thus highlighting increased cell turnover via Wnt signalling pathway inhibition, possibly to combat inflammation and oxidative stress on the ocular surface [18]. The gene discussed is AXIN1; the disease is allergic disease.